Panelists discuss how the evolving treatment landscape for patients with transplant-eligible newly diagnosed multiple myeloma (NDMM) is being shaped by emerging data on optimal treatment sequencing strategies, both in frontline settings and subsequent lines of therapy.
Video content above is prompted by the following:
Stay up to date on recent advances in the multidisciplinary approach to cancer.
2 Commerce Drive
Cranbury, NJ 08512